Horizon Pharma Receives Marketing Authorization for DUEXIS(R) From the United Kingdom Medicines and Healthcare Products Regulatory Agency

Horizon Pharma Receives Marketing Authorization for DUEXIS(R) From the United Kingdom Medicines and Healthcare Products Regulatory Agency

[at noodls] – DEERFIELD, IL — (Marketwire) — 03/07/13 — Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing … more

View todays social media effects on HZNP

View the latest stocks trending across Twitter. Click to view dashboard

See who Horizon is hiring next, click here to view

Share this post